264 related articles for article (PubMed ID: 27025445)
1. Vocal training, levodopa, and environment effects on ultrasonic vocalizations in a rat neurotoxin model of Parkinson disease.
Kelm-Nelson CA; Brauer AF; Ciucci MR
Behav Brain Res; 2016 Jul; 307():54-64. PubMed ID: 27025445
[TBL] [Abstract][Full Text] [Related]
2. Relationships among rat ultrasonic vocalizations, behavioral measures of striatal dopamine loss, and striatal tyrosine hydroxylase immunoreactivity at acute and chronic time points following unilateral 6-hydroxydopamine-induced dopamine depletion.
Grant LM; Barnett DG; Doll EJ; Leverson G; Ciucci M
Behav Brain Res; 2015 Sep; 291():361-371. PubMed ID: 26026785
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of behavioural effects of a selective NMDA NR1A/2B receptor antagonist in the unilateral 6-OHDA lesion rat model.
Warraich ST; Allbutt HN; Billing R; Radford J; Coster MJ; Kassiou M; Henderson JM
Brain Res Bull; 2009 Feb; 78(2-3):85-90. PubMed ID: 18822357
[TBL] [Abstract][Full Text] [Related]
4. An intermittent, controlled-rate, slow progressive degeneration model of Parkinson's disease: antiparkinson effects of Sinemet and protective effects of methylphenidate.
Fleming SM; Delville Y; Schallert T
Behav Brain Res; 2005 Jan; 156(2):201-13. PubMed ID: 15582106
[TBL] [Abstract][Full Text] [Related]
5. Targeted training of ultrasonic vocalizations in aged and Parkinsonian rats.
Johnson AM; Doll EJ; Grant LM; Ringel L; Shier JN; Ciucci MR
J Vis Exp; 2011 Aug; (54):. PubMed ID: 21847085
[TBL] [Abstract][Full Text] [Related]
6. Qualitative changes in ultrasonic vocalization in rats after unilateral dopamine depletion or haloperidol: a preliminary study.
Ciucci MR; Ma ST; Fox C; Kane JR; Ramig LO; Schallert T
Behav Brain Res; 2007 Sep; 182(2):284-9. PubMed ID: 17397940
[TBL] [Abstract][Full Text] [Related]
7. Glial cell line-derived neurotrophic factor-levodopa interactions and reduction of side effects in parkinsonian monkeys.
Miyoshi Y; Zhang Z; Ovadia A; Lapchak PA; Collins F; Hilt D; Lebel C; Kryscio R; Gash DM
Ann Neurol; 1997 Aug; 42(2):208-14. PubMed ID: 9266731
[TBL] [Abstract][Full Text] [Related]
8. Decreased approach behavior and nucleus accumbens immediate early gene expression in response to Parkinsonian ultrasonic vocalizations in rats.
Pultorak JD; Kelm-Nelson CA; Holt LR; Blue KV; Ciucci MR; Johnson AM
Soc Neurosci; 2016; 11(4):365-79. PubMed ID: 26313334
[TBL] [Abstract][Full Text] [Related]
9. Hemiparkinsonism-hemiatrophy syndrome.
Ayromlou H; Najmi S; Arami MA
Arch Iran Med; 2011 Mar; 14(2):152-4. PubMed ID: 21361726
[TBL] [Abstract][Full Text] [Related]
10. Mechanism of action of L-leucyl-glycinamide and its effect on Parkinson's disease.
Xu DL; Yu WC; Pan GB; Chen SD
Adv Neurol; 1987; 45():587-90. PubMed ID: 2881450
[TBL] [Abstract][Full Text] [Related]
11. Increased emissions of 50-kHz ultrasonic vocalizations in hemiparkinsonian rats repeatedly treated with dopaminomimetic drugs: A potential preclinical model for studying the affective properties of dopamine replacement therapy in Parkinson's disease.
Simola N; Serra M; Marongiu J; Costa G; Morelli M
Prog Neuropsychopharmacol Biol Psychiatry; 2021 Jun; 108():110184. PubMed ID: 33242502
[TBL] [Abstract][Full Text] [Related]
12. Exercise Effects on Early Vocal Ultrasonic Communication Dysfunction in a PINK1 Knockout Model of Parkinson's Disease.
Kelm-Nelson CA; Yang KM; Ciucci MR
J Parkinsons Dis; 2015; 5(4):749-63. PubMed ID: 26577653
[TBL] [Abstract][Full Text] [Related]
13. Quantitative Analysis of Catecholamines in the Pink1 -/- Rat Model of Early-onset Parkinson's Disease.
Kelm-Nelson CA; Trevino MA; Ciucci MR
Neuroscience; 2018 May; 379():126-141. PubMed ID: 29496635
[TBL] [Abstract][Full Text] [Related]
14. Effect of acute L-Dopa pretreatment on apomorphine-induced rotational behavior in a rat model of Parkinson's disease.
Mandel RJ
Exp Neurol; 2000 Jan; 161(1):212-9. PubMed ID: 10683287
[TBL] [Abstract][Full Text] [Related]
15. (6aR)-11-amino-N-propyl-noraporphine, a new dopamine D2 and serotonin 5-HT1A dual agonist, elicits potent antiparkinsonian action and attenuates levodopa-induced dyskinesia in a 6-OHDA-lesioned rat model of Parkinson's disease.
Zhao R; Lu W; Fang X; Guo L; Yang Z; Ye N; Zhao J; Liu Z; Jia J; Zheng L; Zhao B; Zhang A; Zhen X
Pharmacol Biochem Behav; 2014 Sep; 124():204-10. PubMed ID: 24955866
[TBL] [Abstract][Full Text] [Related]
16. Intranigral administration of substance P receptor antagonist attenuated levodopa-induced dyskinesia in a rat model of Parkinson's disease.
Yang X; Zhao H; Shi H; Wang X; Zhang S; Zhang Z; Zu J; Zhang W; Shen X; Cui G; Hua F
Exp Neurol; 2015 Sep; 271():168-74. PubMed ID: 26001615
[TBL] [Abstract][Full Text] [Related]
17. Chronic levodopa is not toxic for remaining dopamine neurons, but instead promotes their recovery, in rats with moderate nigrostriatal lesions.
Murer MG; Dziewczapolski G; Menalled LB; García MC; Agid Y; Gershanik O; Raisman-Vozari R
Ann Neurol; 1998 May; 43(5):561-75. PubMed ID: 9585350
[TBL] [Abstract][Full Text] [Related]
18. Antiparkinsonian effects of remacemide hydrochloride, a glutamate antagonist, in rodent and primate models of Parkinson's disease.
Greenamyre JT; Eller RV; Zhang Z; Ovadia A; Kurlan R; Gash DM
Ann Neurol; 1994 Jun; 35(6):655-61. PubMed ID: 8210221
[TBL] [Abstract][Full Text] [Related]
19. Changes in Rat 50-kHz Ultrasonic Vocalizations During Dopamine Denervation and Aging: Relevance to Neurodegeneration.
Johnson AM; Grant LM; Schallert T; Ciucci MR
Curr Neuropharmacol; 2015; 13(2):211-9. PubMed ID: 26411763
[TBL] [Abstract][Full Text] [Related]
20. Behavioural effects of a selective NMDA NR1A/2B receptor antagonist in rats with unilateral 6-OHDA+parafascicular lesions.
Truong L; Allbutt HN; Coster MJ; Kassiou M; Henderson JM
Brain Res Bull; 2009 Feb; 78(2-3):91-6. PubMed ID: 19007866
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
